Form 4: Arteris CEO Sells Shares Under Pre-Planned 10b5-1 Plan

Arteris, Inc. President and CEO, Janac K. Charles, reported the sale of common stock totaling 50,000 shares under a Rule 10b5-1 trading plan.

Summary

• Janac K. Charles, President and CEO, Director, and 10% Owner of Arteris, Inc. (AIP), reported transactions on Form 4.
• On February 9, 2026, 47,244 shares of Common Stock were sold at a weighted average price of $15.2053 per share, with prices ranging from $14.51 to $15.46.
• On February 10, 2026, an additional 2,756 shares of Common Stock were sold at a weighted average price of $15.0322 per share, with prices ranging from $14.85 to $15.22.
• These sales were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2025.
• Following these transactions, Janac K. Charles beneficially owns 139,487 shares directly, 9,349,071 shares indirectly through Bayview Legacy, LLC, and 56,252 shares indirectly through the Charles and Lydia Janac Trust.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative event due to the insider selling by a key executive and significant owner. While the 10b5-1 plan provides a degree of transparency and pre-planning, the act of selling a substantial number of shares can still be perceived as a lack of immediate upside conviction.

Positives

• The reported sales were made pursuant to a Rule 10b5-1 trading plan, which indicates the transactions were pre-scheduled and not based on immediate, non-public information, potentially mitigating concerns about opportunistic insider selling.

Negatives

• The President and CEO, a Director and 10% owner, sold a total of 50,000 shares of common stock, representing a significant insider sale.
• The total value of shares sold was approximately $750,000, which could be interpreted by some investors as a signal of reduced confidence or a move to diversify personal holdings.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported ranges.

Industry Context

StockSavvy.ai notes that Form 4 filings primarily report insider transactions and do not typically provide broader industry context or comparisons to industry trends. The reported sales are specific to the individual's personal trading plan.

Related Party Transactions

• The Reporting Person is the manager of Bayview Legacy, LLC and is deemed to have voting and dispositive power over shares beneficially owned by the LLC.
• Shares are held by the Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.

Stakeholder Impact

• Shareholders may interpret the insider sale as a signal, potentially influencing their perception of the company's near-term prospects or the insider's confidence.
• The existence of a 10b5-1 plan demonstrates adherence to regulatory compliance regarding insider trading, which can be viewed positively by regulatory bodies and governance-focused investors.

Key Dates

Keywords

Arteris, AIP, Form 4, Insider Transaction, Stock Sale, 10b5-1 Plan, CEO, Director, 10% Owner